Koshinski Asset Management’s Invesco S&P 500 Equal Weight Health Care ETF RSPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $371K | Buy |
12,705
+1
| +0% | +$29 | 0.03% | 469 |
|
|
2025
Q1 | $378K | Hold |
12,704
| – | – | 0.03% | 434 |
|
|
2024
Q4 | $372M | Buy |
12,704
+1
| +0% | +$29.3K | 0.03% | 441 |
|
|
2024
Q3 | $409K | Hold |
12,703
| – | – | 0.04% | 416 |
|
|
2024
Q2 | $377K | Sell |
12,703
-350
| -3% | -$10.4K | 0.03% | 414 |
|
|
2024
Q1 | $415K | Sell |
13,053
-7,742
| -37% | -$246K | 0.04% | 357 |
|
|
2023
Q4 | $619K | Buy |
20,795
+7,841
| +61% | +$234K | 0.09% | 247 |
|
|
2023
Q3 | $355K | Buy |
12,954
+4
| +0% | +$110 | 0.04% | 401 |
|
|
2023
Q2 | $386K | Sell |
12,950
-4,510
| -26% | -$134K | 0.04% | 402 |
|
|
2023
Q1 | $509K | Buy |
17,460
+100
| +0.6% | +$2.92K | 0.05% | 323 |
|
|
2022
Q4 | $501K | Sell |
17,360
-280
| -2% | -$8.08K | 0.05% | 360 |
|
|
2022
Q3 | $443K | Buy |
17,640
+10
| +0.1% | +$251 | 0.05% | 341 |
|
|
2022
Q2 | $472K | Hold |
17,630
| – | – | 0.05% | 377 |
|
|
2022
Q1 | $540K | Sell |
17,630
-40
| -0.2% | -$1.23K | 0.04% | 373 |
|
|
2021
Q4 | $566K | Hold |
17,670
| – | – | 0.05% | 377 |
|
|
2021
Q3 | $527K | Buy |
17,670
+4,780
| +37% | +$143K | 0.05% | 387 |
|
|
2021
Q2 | $378K | Sell |
12,890
-4,500
| -26% | -$132K | 0.05% | 383 |
|
|
2021
Q1 | $466K | Hold |
17,390
| – | – | 0.05% | 378 |
|
|
2020
Q4 | $455K | Sell |
17,390
-550
| -3% | -$14.4K | 0.06% | 337 |
|
|
2020
Q3 | $441 | Buy |
17,940
+10
| +0.1% | – | 0.06% | 320 |
|
|
2020
Q2 | $399K | Sell |
17,930
-270
| -1% | -$6.01K | 0.06% | 324 |
|
|
2020
Q1 | $344K | Hold |
18,200
| – | – | 0.07% | 319 |
|
|
2019
Q4 | $401K | Buy |
+18,200
| New | +$401K | 0.07% | 352 |
|
|
2018
Q4 | – | Sell |
-22,450
| Closed | -$463K | – | 491 |
|
|
2018
Q3 | $463K | Buy |
+22,450
| New | +$463K | 0.07% | 343 |
|
|
2018
Q1 | – | Sell |
-19,910
| Closed | -$358K | – | 411 |
|
|
2017
Q4 | $358K | Buy |
+19,910
| New | +$358K | 0.09% | 303 |
|